Nathalie Parisot

Nathalie PARISOT has over 25 years of work experience in the pharmaceutical industry. Nathalie is currently working as the Product Quality Lead Rare Disease at Sobi - Swedish Orphan Biovitrum AB (publ), where they provide cross-functional quality leadership for biologic products. Prior to this, they worked at A3P Association as an Executive Board Member, responsible for organizing forums and overseeing technical presentations. Nathalie also had roles at UCB, where they served as the Global Quality Lead for Biologics and the Vendor Quality Lead for Immunology and Bones. At Merck Group, they managed the team responsible for cleaning validation and established process control strategies. Nathalie also gained experience in quality oversight roles at Celgene and Alexion Pharmaceuticals, Inc. In addition, Nathalie worked at Eli Lilly and Company for a significant part of their career, taking on roles such as Team Leader Sterile Operations Support, QA Specialist and Project Leader, QA Team Leader, Project Engineer, and Quality Assurance Representative.

Nathalie PARISOT completed a Bachelor's degree in Biochemistry and Microbiology from Universite de Lorraine in 1994. Nathalie then pursued a Master's degree in Biotechnology from ENSAIA in 1994-1995. Additionally, Nathalie PARISOT earned another Master's degree in Biochemistry and Microbiology from Universite de Lorraine in 1994-1995. Later, they obtained a Diplôme d'ingénieur/Engineer degree from ENSAIA in 2010-2011.